imipramine

1
Reactions 923 - 12 Oct 2002 Imipramine Skin pigmentation in an elderly patient: case report A 72-year-old woman developed pigmentation of her skin during long-term treatment with imipramine [therapeutic indication not stated]. The woman had been receiving imipramine [dosage not stated] for approximately 30 years when she presented with an 8-year history of progressively worsening slate-grey pigmentation of her face and the extensor surface of her forearms that was photodistributed; her concomitant medication included ranitidine and anacin. Upon examination, relative sparing of the skin folds, mucous membranes, sclerae, teeth and nails was noted. Histological examination of skin biopsy specimens revealed collections of round to ovoid, yellow-brown globular deposits in the upper and mid dermis. The deposits were within macrophages and free within the dermis, and stained for melanin with a Fontana-Masson stain. [Patient outcome not stated.] Author comment: ‘Because imipramine’s chemical structure is similar to chlorpromazine and its active metabolite is desipramine, it is possible that imipramine produces cutaneous hyperpigmentation through similar mechanisms, including abnormal melanogenesis and drug metabolite deposition.’ Angel TA, et al. Photodistributed blue-gray pigmentation of the skin associated with long-term imipramine use. International Journal of Dermatology 41: 327-329, Jun 2002 - USA 807210577 1 Reactions 12 Oct 2002 No. 923 0114-9954/10/0923-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: dangnhan

Post on 18-Mar-2017

218 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Imipramine

Reactions 923 - 12 Oct 2002

Imipramine

Skin pigmentation in an elderly patient: case reportA 72-year-old woman developed pigmentation of her skin

during long-term treatment with imipramine [therapeuticindication not stated].

The woman had been receiving imipramine [dosage notstated] for approximately 30 years when she presented with an8-year history of progressively worsening slate-greypigmentation of her face and the extensor surface of herforearms that was photodistributed; her concomitantmedication included ranitidine and anacin. Upon examination,relative sparing of the skin folds, mucous membranes, sclerae,teeth and nails was noted. Histological examination of skinbiopsy specimens revealed collections of round to ovoid,yellow-brown globular deposits in the upper and mid dermis.The deposits were within macrophages and free within thedermis, and stained for melanin with a Fontana-Masson stain.[Patient outcome not stated.]

Author comment: ‘Because imipramine’s chemicalstructure is similar to chlorpromazine and its active metaboliteis desipramine, it is possible that imipramine producescutaneous hyperpigmentation through similar mechanisms,including abnormal melanogenesis and drug metabolitedeposition.’Angel TA, et al. Photodistributed blue-gray pigmentation of the skin associatedwith long-term imipramine use. International Journal of Dermatology 41: 327-329,Jun 2002 - USA 807210577

1

Reactions 12 Oct 2002 No. 9230114-9954/10/0923-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved